6:02 AM ET
8-K
Shareholder Meeting
Polaryx Therapeutics Shareholder Meeting
Polaryx Therapeutics held its Annual Meeting of Stockholders on September 10, 2026, where shareholders elected Alex Yang and Mitchel Berger as Class I Directors to serve until 2029. Additionally, the appointment of Grant Thornton LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified.